BLFS | BioLife SolutionsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$38.61
+$1.31 (+3.51%)

BioLife Solutions (BLFS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

BLFS stopped trading under this ticker on 5 Oct 2026.

Timeframe summary

Daily as of 5 Oct 16:00 ET

Price
above both $38.61 vs 50 $35.70 / 200 $26.62
Projection
No cross projected
Test
No active test
Last cross
Golden cross 29 Jun 2026 ยท projected 28 bars out

Weekly as of 9 Oct 16:00 ET

Price
above both $38.61 vs 50 $26.64 / 200 $22.45
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 7 Apr 2025 ยท projected 24 bars out ยท tested 4 bars

4-hour as of 5 Oct 16:00 ET

Price
above both $38.61 vs 50 $36.82 / 200 $31.17
Projection
No cross projected
Test
No active test
Last cross
Golden cross 22 May 2026 ยท projected 18 bars out

Cross history

28
crosses on record since 2018
14 golden14 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
29 Jun 2026Golden moderatedaily28 bars outNot tested
22 May 2026Golden4-hour18 bars outNot tested
17 Feb 2026Death moderatedaily25 bars outNot tested
15 Dec 2025Death4-hour18 bars out4 bar cross test
1 Oct 2025Golden moderatedaily30 bars out1 bar cross test

About BLFS

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$27.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.